14th Jul 2022 08:29
Dechra Pharmaceuticals PLC - veterinary products firm - Signs private placement of EUR50 million seven year and EUR100 million ten year senior unsecured notes. Weighted average coupon of the fixed rate notes will equate to 3.8%. Says issue has similar covenants to existing facilities. "The private placement is being undertaken now to achieve the group's aim of ensuring diversified sources of funding and to extend the group's debt maturity profile. All proceeds from the placement will be used to repay existing debt on the group's revolving credit facility." Dechra says. Read More
